L-K6L9, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ470)
Product Quick View
L-K6L9 shows antimicrobial and antibiofilm activities against P. aeruginosa from cystic fibrosis patients. L-K6L9 is stable and resistant to degradation by cystic fibrosis sputum proteases and will not induce bacterial resistance .
| Overview | |
|---|---|
| Synonyms | L-K6L9; L-K6L9 peptide |
| Source | Synthetic |
| Sequence | Leu-Lys-Leu-Leu-Lys-Lys-Leu-Leu-Lys-Lys-Leu-Leu-Lys-Leu-Leu-NH2 |
| Sequence Shortening | LKLLKKLLKKLLKLL-NH2 |
| Activity | Gram-positive bacteria; Gram-negative bacteria; Fungi; Virus; Cancer cells; Apoptosis; Mitochondria |
| Physical State | Powder |
| Purity | >98% |
| Storage | The power can be stored at 4°C for 2 years or at -20°C for 3 years. |
For Research Use Only.
Related products
- Cilagicin, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ339)
- β-defensin 1 (pig) TFA, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ179)
- Myxinidin, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ532)
- Pexiganan acetate, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ75)
- D-K6L9, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ388)
- Indolicidin TFA, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ450)
- Maximin H1, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ516)
- Maximin 1, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ495)
Online Inquiry